Carbamic Acid

Carbamic Acid

SCHEMBL7292389

NC(=O)O.NC(=O)O.OCC(CO)c1ccccc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.57
CYP1A2 P05177 1/20 0.57
PKM P14618 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
GABBR2 O75899 2/20 0.53
GABBR1 Q9UBS5 2/20 0.53
EPHX1 P07099 1/20 0.47
SLC6A3 Q01959 3/20 0.46
LMNA P02545 3/20 0.46
DRD3 P35462 2/20 0.46
CYP2C19 P33261 2/20 0.46
MAPK1 P28482 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
EDNRB P24530 1/20 0.46
MC4R P32245 1/20 0.46
MC3R P41968 1/20 0.46
DRD2 P14416 1/20 0.46
BCAT2 O15382 1/20 0.46
SRC P12931 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148756 0.88 TRPA1 (0.48) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
SCHEMBL8099915 0.86 CYP1A2 (0.47) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
SCHEMBL1059563 0.85 CYP2D6 (0.56) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
SCHEMBL8192677 0.85 CYP2D6 (0.56) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
SCHEMBL8187229 0.85 CYP2D6 (0.56) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
Malonic Acid SCHEMBL18006516 0.84 GABBR2 (0.52) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
Felbamate SCHEMBL1049127 0.83 CYP1A2 (0.86) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
Benzoic Acid SCHEMBL14955665 0.83 TSHR (0.58) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
Phosphonic Acid SCHEMBL29019105 0.82 GSR (0.44) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1
SCHEMBL28431897 0.81 TRPA1 (0.43) CYP2D6CYP1A2PKMSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0491094-B1 Felbamate for treating Lennox-Gastaut syndrome CARTER WALLACE (US) 1996-09-11 EP claimed
EP-0491094-A1 Felbamate for treating Lennox-Gastaut syndrome CARTER-WALLACE, INC. (US) 1992-06-24 EP claimed